Related Experiment Video
Updated: Nov 15, 2025

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic
Qinyu Ma1, Mengmeng Liang2, Yutong Wu1
1Department of Orthopedics Southwest Hospital Third Military Medical University Chongqing 400038 China.
Abstract:
Extracellular vesicles (EVs) play critical roles in regulating bone metastatic microenvironment through mediating intercellular crosstalks. However, little is known about the contribution of EVs derived from cancer cells to the vicious cycle of bone metastasis. Here, we report a direct regulatory mode between tumour cells and osteoclasts in metastatic niche of prostate cancer via vesicular miRNAs transfer. Combined analysis of miRNAs profiles both in tumour-derived small EVs (sEVs) and osteoclasts identified miR-152-3p as a potential osteolytic molecule. sEVs were enriched in miR-152-3p, which targets osteoclastogenic regulator MAFB. Blocking miR-152-3p in sEVs upregulated the expression of MAFB and impaired osteoclastogenesis in vitro. In vivo experiments of xenograft mouse model found that blocking of miR-152-3p in sEVs significantly slowed down the loss of trabecular architecture, while systemic inhibition of miR-152-3p using antagomir-152-3p reduced the osteolytic lesions of cortical bone while preserving basic trabecular architecture. Our findings suggest that miR-152-3p carried by prostate cancer-derived sEVs deliver osteolytic signals from tumour cells to osteoclasts, facilitating osteolytic progression in bone metastasis.
Insights
Prostate cancer cells release microRNAs (miRNAs) in extracellular vesicles (EVs) that promote bone metastasis. Blocking miR-152-3p in these EVs reduces osteolytic lesions and preserves bone structure.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Extracellular vesicles (EVs) mediate intercellular communication in the bone metastatic microenvironment.
- The role of cancer cell-derived EVs in the bone metastasis cycle, particularly in prostate cancer, remains unclear.
Purpose of the Study:
- To investigate the direct regulatory role of tumor cell-derived EVs in prostate cancer bone metastasis.
- To identify specific molecular mechanisms, such as microRNA (miRNA) transfer, involved in this process.
Main Methods:
- Analysis of miRNA profiles in tumor-derived small EVs (sEVs) and osteoclasts.
- In vitro studies to assess the effect of miR-152-3p on osteoclastogenesis.
- In vivo xenograft mouse models to evaluate the impact of blocking miR-152-3p on bone metastasis.
Main Results:
- miR-152-3p was identified as a key osteolytic molecule enriched in prostate cancer-derived sEVs.
- Blocking miR-152-3p in sEVs upregulated MAFB expression and impaired osteoclastogenesis in vitro.
- In vivo, blocking miR-152-3p in sEVs reduced trabecular bone loss and osteolytic lesions, preserving bone architecture.
Conclusions:
- Prostate cancer-derived sEVs transfer miR-152-3p to osteoclasts, delivering osteolytic signals.
- This miRNA-mediated crosstalk facilitates osteolytic progression in bone metastasis.
- Targeting miR-152-3p in EVs presents a potential therapeutic strategy for prostate cancer bone metastasis.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Osteoclasts in Bone Remodeling
Cancer Cell Migration through Invadopodia
The Tumor Microenvironment
Paracrine Signaling

